MOUNTAIN VIEW, Calif., Dec. 18, 2018 /PRNewswire/ -- Livongo Health, the first Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced Dr. Jennifer Schneider's promotion to President. Schneider will broaden her responsibilities at the Company and assume the role of President, with responsibility for Product, Data Science, Software Engineering, Marketing, and Clinical Operations. Schneider previously served as the Company's Chief Medical Officer.
Zane Burke, newly appointed Chief Executive Officer of Livongo, commented, "The opportunity to partner with Jenny and the rest of the Livongo executive team to build on the success Livongo has enjoyed to date is something I'm very much looking forward to."
Schneider joined Livongo in 2015, having most recently served as Castlight's Chief Medical Officer. At the time, it was considered a coupe to land such a highly regarded industry leader for the company. Over the last three years, she has built the company's clinical and data science operations, now considered industry-leading, and has helped to drive results that demonstrate a substantial and sustained reduction in A1c and financial ROI for clients. Over the last 12 months, her responsibilities have expanded in line with the Company's growth, particularly in the strategy realm as the Company has moved beyond diabetes to focus on the health of the whole person.
"I'm excited about the possibilities in front of us as the leader in Applied Health Signals," said Schneider. "The marketplace is recognizing our differentiated offering, and we're now serving more than 600 of the largest, most innovative self-insured employers in the U.S., the two largest pharmacy benefit managers and a growing number of payers and health services organizations. As we rapidly grow our business and build new capabilities, we are able to aggregate and interpret more data on more conditions, and deliver actionable, personalized and timely health signals to more and more people with chronic conditions empowering them get and stay healthy."
Glen Tullman, Executive Chairman of Livongo, said, "On behalf of all of our team members and our executive leadership, I want to congratulate Jenny on a well-earned and deserved promotion, one which acknowledges the increasingly broad leadership role she has been playing in the business. I'm looking forward to working with Zane and Jenny and the entire leadership team to take the company to the next level, empowering our Members to live better and healthier lives."
Dr. Schneider previously held leadership roles in the provider setting as a health outcomes researcher and Chief Resident at Stanford University, and practiced medicine as an attending physician at Stanford University, the VA Palo Alto Health Care System, and Kaiser Permanente. Dr. Schneider has an undergraduate degree from the College of the Holy Cross, a Doctor of Medicine degree from Johns Hopkins School of Medicine, and a Master of Science degree in Health Services Research from Stanford University. She completed her internal medicine residency at Stanford University Hospital.
Livongo is the leading Applied Health Signals company that empowers people with chronic conditions to live better and healthier lives. Livongo's team of data scientists aggregate and interpret substantial amounts of health data and information to create Actionable, Personalized, and Timely insights and Health Nudges delivered to our members to make it easier for them to stay healthier. Livongo is the first company at the intersection of data science, behavior enablement, and clinical impact with the technologies and capabilities to Silence Noisy Healthcare™. Our approach is leading to better clinical and financial outcomes while creating a better experience for people with chronic conditions. For more information, visit: www.livongo.com.
SOURCE Livongo Health